BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10729776)

  • 1. Differential regulation of activation-induced cell death in individual human T cell clones.
    Janssen O; Stocker A; Sanzenbacher R; Oberg HH; Siddiqi MA; Kabelitz D
    Int Arch Allergy Immunol; 2000 Mar; 121(3):183-93. PubMed ID: 10729776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation-induced T cell death: resistance or susceptibility correlate with cell surface fas ligand expression and T helper phenotype.
    Oberg HH; Lengl-Janssen B; Kabelitz D; Janssen O
    Cell Immunol; 1997 Oct; 181(1):93-100. PubMed ID: 9344501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional CD95 ligand and CD95 death-inducing signaling complex in activation-induced cell death and doxorubicin-induced apoptosis in leukemic T cells.
    Fulda S; Strauss G; Meyer E; Debatin KM
    Blood; 2000 Jan; 95(1):301-8. PubMed ID: 10607716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential ability of T cell subsets to undergo activation-induced cell death.
    Varadhachary AS; Perdow SN; Hu C; Ramanarayanan M; Salgame P
    Proc Natl Acad Sci U S A; 1997 May; 94(11):5778-83. PubMed ID: 9159150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primed T cells are more resistant to Fas-mediated activation-induced cell death than naive T cells.
    Inaba M; Kurasawa K; Mamura M; Kumano K; Saito Y; Iwamoto I
    J Immunol; 1999 Aug; 163(3):1315-20. PubMed ID: 10415029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of T cell clonal anergy results in resistance, whereas CD28-mediated costimulation primes for susceptibility to Fas- and Bax-mediated programmed cell death.
    Boussiotis VA; Lee BJ; Freeman GJ; Gribben JG; Nadler LM
    J Immunol; 1997 Oct; 159(7):3156-67. PubMed ID: 9317113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive caspase activation and impaired death-inducing signaling complex formation in CD95-resistant, long-term activated, antigen-specific T cells.
    Strauss G; Knape I; Melzner I; Debatin KM
    J Immunol; 2003 Aug; 171(3):1172-82. PubMed ID: 12874203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential susceptibility to HIV-GP120-sensitized apoptosis in CD4+ T-cell clones with different T-helper phenotypes: role of CD95/CD95L interactions.
    Accornero P; Radrizzani M; Delia D; Gerosa F; Kurrle R; Colombo MP
    Blood; 1997 Jan; 89(2):558-69. PubMed ID: 9002959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation induces apoptosis in Herpesvirus saimiri-transformed T cells independent of CD95 (Fas, APO-1).
    Bröker BM; Kraft MS; Klauenberg U; Le Deist F; de Villartay JP; Fleckenstein B; Fleischer B; Meinl E
    Eur J Immunol; 1997 Nov; 27(11):2774-80. PubMed ID: 9394798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of T-cell receptor-induced signaling is crucial for CD95 ligand up-regulation and protects cutaneous T-cell lymphoma cells from activation-induced cell death.
    Klemke CD; Brenner D; Weiss EM; Schmidt M; Leverkus M; Gülow K; Krammer PH
    Cancer Res; 2009 May; 69(10):4175-83. PubMed ID: 19435902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An unexpected role for FosB in activation-induced cell death of T cells.
    Baumann S; Hess J; Eichhorst ST; Krueger A; Angel P; Krammer PH; Kirchhoff S
    Oncogene; 2003 Mar; 22(9):1333-9. PubMed ID: 12618758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Th1 and Th2 subsets equally undergo Fas-dependent and -independent activation-induced cell death.
    Watanabe N; Arase H; Kurasawa K; Iwamoto I; Kayagaki N; Yagita H; Okumura K; Miyatake S; Saito T
    Eur J Immunol; 1997 Aug; 27(8):1858-64. PubMed ID: 9295019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TCR engagement regulates differential responsiveness of human memory T cells to Fas (CD95)-mediated apoptosis.
    Di Somma MM; Somma F; Gilardini Montani MS; Mangiacasale R; Cundari E; Piccolella E
    J Immunol; 1999 Apr; 162(7):3851-8. PubMed ID: 10201902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation-induced cell death of human T-cell subsets is mediated by Fas and granzyme B but is independent of TNF-alpha.
    Gorak-Stolinska P; Truman JP; Kemeny DM; Noble A
    J Leukoc Biol; 2001 Nov; 70(5):756-66. PubMed ID: 11698496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 trans-activator of transcription substitutes for oxidative signaling in activation-induced T cell death.
    Gülow K; Kaminski M; Darvas K; Süss D; Li-Weber M; Krammer PH
    J Immunol; 2005 May; 174(9):5249-60. PubMed ID: 15843521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-2 induces Fas ligand/Fas (CD95L/CD95) cytotoxicity in CD8+ and CD4+ T lymphocyte clones.
    Esser MT; Dinglasan RD; Krishnamurthy B; Gullo CA; Graham MB; Braciale VL
    J Immunol; 1997 Jun; 158(12):5612-8. PubMed ID: 9190908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ZAP-70 tyrosine kinase is required for the up-regulation of Fas ligand in activation-induced T cell apoptosis.
    Eischen CM; Williams BL; Zhang W; Samelson LE; Lynch DH; Abraham RT; Leibson PJ
    J Immunol; 1997 Aug; 159(3):1135-9. PubMed ID: 9233606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of activation-induced cell death in the differentiation of T-helper-cell subsets.
    Roberts AI; Devadas S; Zhang X; Zhang L; Keegan A; Greeneltch K; Solomon J; Wei L; Das J; Sun E; Liu C; Yuan Z; Zhou JN; Shi Y
    Immunol Res; 2003; 28(3):285-93. PubMed ID: 14713720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to activation-induced cell death and bystander cytotoxicity via the Fas/Fas ligand pathway are implicated in the pathogenesis of cutaneous T cell lymphomas.
    Ni X; Zhang C; Talpur R; Duvic M
    J Invest Dermatol; 2005 Apr; 124(4):741-50. PubMed ID: 15816832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral IFN-regulatory factors inhibit activation-induced cell death via two positive regulatory IFN-regulatory factor 1-dependent domains in the CD95 ligand promoter.
    Kirchhoff S; Sebens T; Baumann S; Krueger A; Zawatzky R; Li-Weber M; Meinl E; Neipel F; Fleckenstein B; Krammer PH
    J Immunol; 2002 Feb; 168(3):1226-34. PubMed ID: 11801659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.